Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.
Arch Ophthalmol. 2010 Oct;128(10):1273-9. doi: 10.1001/archophthalmol.2010.223.
Arch Ophthalmol. 2010.
PMID: 20937996